Home page532523 • BOM
add
Biocon Ltd
Chiusura precedente
323,15 ₹
Intervallo giornaliero
322,45 ₹ - 332,30 ₹
Intervallo annuale
231,35 ₹ - 395,65 ₹
Cap di mercato
396,60Â Mld INR
Volume medio
170.803,00
Rapporto P/E
27,55
Dividendo/Prezzo
0,15%
Borsa valori principale
NSE
Notizie del mercato finanziario
Dati finanziari
Conto economico
Entrate
Utile netto
(INR) | set 2024info | Variazione Y/Y |
---|---|---|
Entrate | 35,90Â Mld | 3,70% |
Spese di gestione | 21,42Â Mld | 8,03% |
Utile netto | -160,00Â Mln | -112,74% |
Margine di profitto netto | -0,45 | -112,40% |
Utili per azione | -0,19 | -115,53% |
EBITDA | 6,78Â Mld | -6,58% |
Aliquota fiscale effettiva | 72,46% | — |
Stato patrimoniale
Totale attivo
Totale passivo
(INR) | set 2024info | Variazione Y/Y |
---|---|---|
Investimenti cash/breve termine | 26,50Â Mld | -30,00% |
Totale attivo | 571,28Â Mld | 4,67% |
Totale passivo | 304,08Â Mld | 0,36% |
Patrimonio netto totale | 267,20 Mld | — |
Azioni in circolazione | 1,23 Mld | — |
Prezzo/valore contabile | 1,89 | — |
Redditività dell'attivo | — | — |
Rendimento sul capitale | 1,56% | — |
Flusso di cassa
Flusso di cassa netto
(INR) | set 2024info | Variazione Y/Y |
---|---|---|
Utile netto | -160,00Â Mln | -112,74% |
Liquidità di esercizio | — | — |
Contanti da investimenti | — | — |
Contanti da finanziamenti | — | — |
Flusso di cassa netto | — | — |
Flusso di cassa libero | — | — |
Informazioni
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, India. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
Fondazione
1978
Sito web
Dipendenti
16.315